ARB2A and neoplasm: Our in vivo experiments showed that FAM172A knockdown significantly reduced CD31-positive microvessel density in xenograft tumors, indicating impaired angiogenesis and suggesting that FAM172A contributes to EOC progression partly by facilitating tumor vascularization.